Swiss pharmaceutical giant Roche invests $50 billion in the US

Swiss pharmaceutical giant Roche announced today that it will invest $50 billion in the United States over the next five years.

The company said this commitment includes the establishment of new state-of-the-art research and development sites, as well as new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts, and California.

The company added that these investments are expected to create more than 12,000 new jobs, including approximately 6,500 in the construction sector, in addition to 1,000 jobs in the new and expanded facilities, according to the German News Agency.

“Roche is a Swiss company with a long-standing heritage in more than 130 countries around the world,” said CEO Thomas Schinecker. “The investments announced today underscore our unwavering commitment to research, development, and manufacturing in the United States.”

The company indicated that the additional production capacity will enable it to export more medicines from the United States than it imports.